Beth Seidenberg Insider Profile

1,047 Followers
Beth Seidenberg, Director at Epizyme, holds 135.56K shares in Vera Therapeutics (Ticker: VERA), holds 5.35M shares in Progyny (Ticker: PGNY), holds 735.98K shares in Kyverna Therapeutics, Inc. (Ticker: KYTX).
tipranks
Beth Seidenberg

Beth Seidenberg
Epizyme (EPZM)
Director

Ranked #5 out of 99,218 Corporate Insiders

Profitable Transactions

88%
15 out of 17 Profitable Transactions

Average Return

+368.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$197M
45.09%
29.51%
11.44%
6.13%
7.83% Others
A breakdown of Beth Seidenberg's holdings

Insider Roles

Progyny
(PGNY)
Director
ACELYRIN, INC.
(SLRN)
Director
Atara Biotherapeutics
(ATRA)
Director
Sagimet Biosciences, Inc. Class A
(SGMT)
Director
+4 other positions
Roles that Beth Seidenberg holds in companies

Most Profitable Insider Trade

Stock:
Atara Biotherapeutics
(ATRA)
Rating:Informative Buy
Date:Oct 15, 2014 - Oct 15, 2015
Return:+800.00%
The most profitable trade made by Beth Seidenberg

Beth Seidenberg's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EPZM
Epizyme
Jun 07, 2019
Uninformative Buy
12.69K
$6.06M
ARMO
Armo Biosciences Inc
Jun 22, 2018
Uninformative Sell
213.33M
$0.00
Progyny
May 28, 2024
Director
Uninformative Buy
$88.80M
Vera Therapeutics
Oct 30, 2024
Director
Uninformative Sell
720.46K
$6.52M
ACELYRIN, INC.
May 11, 2023
Director
Uninformative Buy
$58.12M
Sagimet Biosciences, Inc. Class A
Jul 20, 2023
Director
Uninformative Buy
$12.06M
Kyverna Therapeutics, Inc.
Feb 14, 2024
Director, Ten Percent Owner
Uninformative Buy
$3.89M
TSRO
Tesaro
Jan 24, 2019
Uninformative Sell
166.66M
$0.00
Atara Biotherapeutics
Jun 02, 2023
Director
Uninformative Buy
$22.54M
Amgen
Sr VP, Dev & Chief Medical Ofc
$4.99M
BioCryst
Director
$23.34K
List of latest transactions for each holding click on a transaction to see Beth Seidenberg's performance on stock

Beth Seidenberg insider profile FAQ

What is the percentage of profitable transactions made by Beth Seidenberg?
The percentage of profitable transactions made by Beth Seidenberg is 88%.
    What is the average return per transaction made by Beth Seidenberg?
    The average return per transaction made by Beth Seidenberg is 368.20%.
      What stocks does Beth Seidenberg hold?
      Beth Seidenberg holds: EPZM, ARMO, PGNY, VERA, SLRN, SGMT, KYTX, TSRO, ATRA, AMGN, BCRX stocks.
        What was Beth Seidenberg’s latest transaction?
        Beth Seidenberg latest transaction was an Uninformative Sell of $720.46K.
          What was Beth Seidenberg's most profitable transaction?
          Beth Seidenberg’s most profitable transaction was an Informative Buy of ATRA stock on October 15, 2014. The return on the trade was 800.00%.
            What is Beth Seidenberg's role in Epizyme?
            Beth Seidenberg's role in Epizyme is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.